Waldencast (WALD) Projected to Post Earnings on Tuesday

Waldencast (NASDAQ:WALD - Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $68.27 million for the quarter.

Waldencast Stock Performance

Shares of WALD stock traded down $0.02 during trading hours on Tuesday, reaching $2.70. 458 shares of the company's stock were exchanged, compared to its average volume of 125,500. Waldencast has a fifty-two week low of $2.31 and a fifty-two week high of $5.21. The stock's 50 day moving average is $2.90 and its 200-day moving average is $3.24. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Alliance Global Partners initiated coverage on shares of Waldencast in a research note on Tuesday, April 22nd. They issued a "buy" rating and a $5.00 target price for the company. Telsey Advisory Group restated an "outperform" rating and issued a $5.00 target price on shares of Waldencast in a research note on Tuesday. Industrial Alliance Securities set a $5.00 target price on Waldencast in a research report on Tuesday, April 22nd. Finally, DA Davidson reissued a "buy" rating and set a $7.50 price target on shares of Waldencast in a research report on Wednesday, March 19th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $5.40.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.